| Product Code: ETC7625988 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Ireland Cell And Gene Therapy Manufacturing Market Overview |
3.1 Ireland Country Macro Economic Indicators |
3.2 Ireland Cell And Gene Therapy Manufacturing Market Revenues & Volume, 2021 & 2031F |
3.3 Ireland Cell And Gene Therapy Manufacturing Market - Industry Life Cycle |
3.4 Ireland Cell And Gene Therapy Manufacturing Market - Porter's Five Forces |
3.5 Ireland Cell And Gene Therapy Manufacturing Market Revenues & Volume Share, By Therapy Type, 2021 & 2031F |
3.6 Ireland Cell And Gene Therapy Manufacturing Market Revenues & Volume Share, By Scale, 2021 & 2031F |
3.7 Ireland Cell And Gene Therapy Manufacturing Market Revenues & Volume Share, By Mode, 2021 & 2031F |
3.8 Ireland Cell And Gene Therapy Manufacturing Market Revenues & Volume Share, By Workflow, 2021 & 2031F |
4 Ireland Cell And Gene Therapy Manufacturing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing investments and funding in cell and gene therapy research and development in Ireland |
4.2.2 Favorable government regulations and policies promoting cell and gene therapy manufacturing in Ireland |
4.3 Market Restraints |
4.3.1 Lack of skilled workforce specialized in cell and gene therapy manufacturing |
4.3.2 High initial setup costs and complex manufacturing processes for cell and gene therapies |
5 Ireland Cell And Gene Therapy Manufacturing Market Trends |
6 Ireland Cell And Gene Therapy Manufacturing Market, By Types |
6.1 Ireland Cell And Gene Therapy Manufacturing Market, By Therapy Type |
6.1.1 Overview and Analysis |
6.1.2 Ireland Cell And Gene Therapy Manufacturing Market Revenues & Volume, By Therapy Type, 2021- 2031F |
6.1.3 Ireland Cell And Gene Therapy Manufacturing Market Revenues & Volume, By Cell therapy manufacturing, 2021- 2031F |
6.1.4 Ireland Cell And Gene Therapy Manufacturing Market Revenues & Volume, By Gene therapy manufacturing, 2021- 2031F |
6.2 Ireland Cell And Gene Therapy Manufacturing Market, By Scale |
6.2.1 Overview and Analysis |
6.2.2 Ireland Cell And Gene Therapy Manufacturing Market Revenues & Volume, By Pre-commercial/R&D scale manufacturing, 2021- 2031F |
6.2.3 Ireland Cell And Gene Therapy Manufacturing Market Revenues & Volume, By Commercial scale manufacturing, 2021- 2031F |
6.3 Ireland Cell And Gene Therapy Manufacturing Market, By Mode |
6.3.1 Overview and Analysis |
6.3.2 Ireland Cell And Gene Therapy Manufacturing Market Revenues & Volume, By Contract manufacturing, 2021- 2031F |
6.3.3 Ireland Cell And Gene Therapy Manufacturing Market Revenues & Volume, By In-house manufacturing, 2021- 2031F |
6.4 Ireland Cell And Gene Therapy Manufacturing Market, By Workflow |
6.4.1 Overview and Analysis |
6.4.2 Ireland Cell And Gene Therapy Manufacturing Market Revenues & Volume, By Cell processing, 2021- 2031F |
6.4.3 Ireland Cell And Gene Therapy Manufacturing Market Revenues & Volume, By Cell banking, 2021- 2031F |
6.4.4 Ireland Cell And Gene Therapy Manufacturing Market Revenues & Volume, By Process development, 2021- 2031F |
6.4.5 Ireland Cell And Gene Therapy Manufacturing Market Revenues & Volume, By Fill & finish operations, 2021- 2031F |
6.4.6 Ireland Cell And Gene Therapy Manufacturing Market Revenues & Volume, By Analytical and quality testing, 2021- 2031F |
6.4.7 Ireland Cell And Gene Therapy Manufacturing Market Revenues & Volume, By Raw material testing, 2021- 2031F |
6.4.8 Ireland Cell And Gene Therapy Manufacturing Market Revenues & Volume, By Others, 2021- 2031F |
6.4.9 Ireland Cell And Gene Therapy Manufacturing Market Revenues & Volume, By Others, 2021- 2031F |
7 Ireland Cell And Gene Therapy Manufacturing Market Import-Export Trade Statistics |
7.1 Ireland Cell And Gene Therapy Manufacturing Market Export to Major Countries |
7.2 Ireland Cell And Gene Therapy Manufacturing Market Imports from Major Countries |
8 Ireland Cell And Gene Therapy Manufacturing Market Key Performance Indicators |
8.1 Number of new partnerships or collaborations formed between Irish companies and international cell and gene therapy firms |
8.2 Number of patents filed for cell and gene therapy manufacturing technologies in Ireland |
8.3 Percentage increase in research and development expenditure in the cell and gene therapy sector in Ireland |
8.4 Number of regulatory approvals obtained for cell and gene therapy manufacturing facilities in Ireland |
8.5 Percentage increase in the number of skilled professionals trained in cell and gene therapy manufacturing in Ireland |
9 Ireland Cell And Gene Therapy Manufacturing Market - Opportunity Assessment |
9.1 Ireland Cell And Gene Therapy Manufacturing Market Opportunity Assessment, By Therapy Type, 2021 & 2031F |
9.2 Ireland Cell And Gene Therapy Manufacturing Market Opportunity Assessment, By Scale, 2021 & 2031F |
9.3 Ireland Cell And Gene Therapy Manufacturing Market Opportunity Assessment, By Mode, 2021 & 2031F |
9.4 Ireland Cell And Gene Therapy Manufacturing Market Opportunity Assessment, By Workflow, 2021 & 2031F |
10 Ireland Cell And Gene Therapy Manufacturing Market - Competitive Landscape |
10.1 Ireland Cell And Gene Therapy Manufacturing Market Revenue Share, By Companies, 2024 |
10.2 Ireland Cell And Gene Therapy Manufacturing Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here